Last updated on October 2018

Safety Tolerability Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Na ve Patients With Chronic HBV Infection


Brief description of study

To examine the safety and tolerability of IONIS-HBVRx administration to treatment-naive patients with chronic hepatitis B virus infection

Detailed Study Description

This study examines the effects of IONIS-HBVRx or placebo (3:1 randomization) administered subcutaneously to treatment-nave patients who are chronically infected with HBV and the effects of subsequent nucleos(t)ide analogue treatment on these patients.

Clinical Study Identifier: NCT02981602

Contact Investigators or Research Sites near you

Start Over

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.